FR2740338B1 - STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINE - Google Patents

STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINE

Info

Publication number
FR2740338B1
FR2740338B1 FR9514238A FR9514238A FR2740338B1 FR 2740338 B1 FR2740338 B1 FR 2740338B1 FR 9514238 A FR9514238 A FR 9514238A FR 9514238 A FR9514238 A FR 9514238A FR 2740338 B1 FR2740338 B1 FR 2740338B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
compositions containing
stabilized pharmaceutical
dobutamine
containing dobutamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9514238A
Other languages
French (fr)
Other versions
FR2740338A1 (en
Inventor
Madar Daniele Kalifa
Francois Dietlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9514238A priority Critical patent/FR2740338B1/en
Publication of FR2740338A1 publication Critical patent/FR2740338A1/en
Application granted granted Critical
Publication of FR2740338B1 publication Critical patent/FR2740338B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9514238A 1995-12-01 1995-12-01 STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINE Expired - Fee Related FR2740338B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9514238A FR2740338B1 (en) 1995-12-01 1995-12-01 STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514238A FR2740338B1 (en) 1995-12-01 1995-12-01 STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINE

Publications (2)

Publication Number Publication Date
FR2740338A1 FR2740338A1 (en) 1997-04-30
FR2740338B1 true FR2740338B1 (en) 1997-12-05

Family

ID=9485067

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9514238A Expired - Fee Related FR2740338B1 (en) 1995-12-01 1995-12-01 STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINE

Country Status (1)

Country Link
FR (1) FR2740338B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (en) * 2000-06-06 2004-09-24 Pharmatop NOVEL AQUEOUS FORMULATIONS OF OXIDATION-SENSITIVE ACTIVE INGREDIENTS AND PROCESS FOR OBTAINING THEM

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3808317A (en) * 1969-10-29 1974-04-30 Alcon Labor Inc Stabilized aqueous borate complexes of biologically active catechol amines
FR2231377B1 (en) * 1973-05-29 1977-11-04 Barnes Hind Pharm Inc
RO93391B (en) * 1984-12-20 1988-03-31 Eli Lilly And Company Process for preparing dobutamine salts
AU5680994A (en) * 1992-12-10 1994-07-04 Abbott Laboratories Stabilized catecholamine solutions

Also Published As

Publication number Publication date
FR2740338A1 (en) 1997-04-30

Similar Documents

Publication Publication Date Title
CY2005007I1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DARIFENACINE
DK0747050T3 (en) Pharmaceutical compositions containing irbesartan
DZ2086A1 (en) Substituted benzylaminopiperidines and pharmaceutical compositions containing them.
DE69634053D1 (en) Oral drug composition containing 2-methyl-thienobenzodiazepine
ITRM960810A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS OR MACROLIDS
MA24466A1 (en) COMPOSITIONS CONTAINING TETRAHYDROLISTATIN
IS4706A (en) pharmaceutical compositions
MA26553A1 (en) ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
DZ2361A1 (en) 6-phenylpyridyl-2-amine derivatives and pharmaceutical compositions containing them
DE19681727T1 (en) Capsule / particle containing shampoo composition
DZ1916A1 (en) New compounds and pharmaceutical compositions containing them.
BR9607483A (en) Liquid stabilized tissue compositions
DE69610553T2 (en) DEODORANT COMPOSITIONS
FR2732592B1 (en) SELF-TANNING COSMETIC COMPOSITIONS
DE69632237D1 (en) Cosmetic compositions containing tricholine citrate
DE69614407D1 (en) PHARMACEUTICAL COMPOSITIONS
LV11727A (en) Pharmaceutical composition
FI973229A0 (en) New pharmaceutical composition
ITMI950379A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AN ANTI-INFLAMMATORY AGENT AND AN ANTIMICROBIAL AGENT
FI973280A (en) Pharmaceutical composition
FR2740338B1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINE
FR2677250B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DISOD ADENOSINE-5-TRIPHOSPHATE.
BR9605777A (en) Pharmaceutical composition
FR2737114B1 (en) SCENTED COSMETIC COMPOSITION
FR2715564B1 (en) Pharmaceutical composition containing N-acetyl-cysteine.

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse